Efficacy and safety of a low-dose continuous combined hormone replacement therapy with 0.5 mg 17β-estradiol and 2.5 mg dydrogesterone in subgroups of postmenopausal women with vasomotor symptoms
2020 ◽
Vol 139
◽
pp. 20-26
Sophia Tsiligiannis
◽
Bettina C. Wick-Urban
◽
Jan van der Stam
◽
John C. Stevenson